ELIQUENT Life Sciences acquired Azzur Consulting to enhance its consulting capabilities in the pharmaceutical and life sciences sectors.
Information on the Target
Azzur Consulting specializes in providing comprehensive consulting services to the pharmaceutical, biotechnology, and medical device sectors. With a strong focus on Good Practice (GxP) compliance, Azzur assists its clients in starting, scaling, and sustaining their organizational operations. The firm's innovative solutions have established it as a vital partner for leading manufacturers seeking efficiency and compliance in their processes.
As an expert in life sciences, Azzur Consulting offers a range of services that include quality assurance, regulatory affairs, and operational excellence tailored to the unique needs of each manufacturer. The company positions itself as a key facilitator for clients navigating the complexities of GxP regulations, ensuring they maintain high standards while achieving industry goals.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The life sciences industry in the United States is a rapidly evolving sector, driven by ongoing advancements in biotechnology and medical technology. The demand for innovative healthcare solutions has surged, lea
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
Fortified Health Security → Latitude Information Security
2026
LPOXY Therapeutics, Inc. → Xeno Biosciences Inc.
2025
ELIQUENT Life Sciences
invested in
Azzur Consulting
in 2025
in a Other deal